throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`QUALCOMM INCORPORATED,
`
`Petitioner,
`
`v.
`
`UNM RAINFOREST INNOVATIONS,
`
`Patent Owner.
`_____________________
`Case IPR2021-00375
`
`Patent No. 8,265,096 B2
`_____________________
`
`PETITIONER’S MOTION FOR JOINDER UNDER 35 U.S.C.
`§ 315(c), 37 C.F.R. § 42.22, AND 42.122(b)
`
`
`
`
`

`

`TABLE OF CONTENTS
`
`
`I. STATEMENT OF THE PRECISE RELIEF REQUESTED .............................. 1
`II. BACKGROUND AND RELATED PROCEEDINGS ....................................... 3
`III. ARGUMENT ...................................................................................................... 4
`A. Qualcomm’s Motion for Joinder Is Timely ...................................................... 4
`B. The Kyocera Factors Weigh in Favor of Joinder ............................................. 5
`1.
`Joinder of Qualcomm is Appropriate Because It Will Promote an
`Efficient Determination of the Validity of the ’096 Patent Without Prejudice to
`Any Party ............................................................................................................ 5
`2. Qualcomm’s Petition Does Not Raise Any New Grounds of
`Unpatentability and Therefore Does Not Add Additional Complexity to the
`Grounds in Intel’s Petition .................................................................................. 7
`3.
`Joinder Would Not Affect the Schedule in the Intel IPR ........................... 8
`4.
`Joinder Will Simplify Briefing and Discovery Because Qualcomm Has
`Agreed to Consolidated Filings and an Understudy Role ................................... 9
`C. The Board Has Granted Joinder under these Circumstances, Finding No
`Undue Burden or Prejudice .................................................................................. 11
`IV. CONCLUSION ................................................................................................. 11
`
`
`
`
`
`
`
`
`
`
`
`

`

`I.
`
`STATEMENT OF THE PRECISE RELIEF REQUESTED
`Pursuant to 35 U.S.C. § 315(c) and 37 C.F.R. §§ 42.22 and 42.122(b),
`
`Qualcomm Incorporated (“Petitioner”) moves for joinder with the Inter Partes
`
`Review of U.S. Patent No. 8,265,096 (“the ’096 patent”), Intel Corp. v. UNM
`
`Rainforest Innovations, IPR2020-01576 (“the Intel IPR”), for which the petition for
`
`inter partes review was filed on September 14, 2020 (“the Intel Petition”) and is
`
`currently pending. IPR2020-01576, Paper 2. This motion is timely because it is filed
`
`“no later than one month after the institution date” of the Intel IPR. 37 C.F.R. §
`
`42.122(b); Central Security Group – Nationwide, Inc. v. Ubiquitous Connectivity,
`
`LP, IPR2019-01609, Paper 11, at 8-9 (P.T.A.B. Feb. 26, 2020) (stating that §
`
`42.122(b) is “[t]he only timing requirement for a motion for joinder”); Dell Inc. v.
`
`Neodron Ltd., IPR2020-00731, Paper 9, at 5 (P.T.A.B. July 31, 2020) (granting
`
`motion for joinder to an IPR proceeding that was not instituted until after the motion
`
`for joinder was filed). Petitioner requests that action on this motion be held in
`
`abeyance until, and only in the event of, institution of the Intel IPR. Petitioner
`
`understands that Intel, the petitioner in the Intel IPR, does not oppose Petitioner’s
`
`request for joinder.
`
`Qualcomm’s Petition relies on the references cited and follows the arguments
`
`raised in the Intel Petition, and is essentially a copy of the Intel Petition. Petitioner
`
`here asserts that the same claims are invalid based on substantially the same
`
`
`
`-1-
`
`

`

`arguments presented in the Intel IPR. Moreover, Petitioner’s declaration is
`
`substantively identical to the declaration in the Intel IPR. Qualcomm’s Petition
`
`includes the identical grounds presented in the Intel Petition and therefore would
`
`create no additional burden for the Board, Intel, or UNM Rainforest Innovations if
`
`joined. Joinder would therefore lead to an efficient resolution of the validity of the
`
`’096 patent.
`
`Counsel for Qualcomm and counsel for Intel met and conferred as to the level
`
`of cooperation between Intel and Qualcomm that will be maintained if Qualcomm’s
`
`motion for joinder is granted. Qualcomm stipulates that if joinder is granted, it will
`
`cooperate with Intel in the joined proceeding, whether at hearings, at depositions, in
`
`filings, or otherwise, as outlined below. Unless Intel is terminated from the
`
`proceedings, Qualcomm will proceed in a limited “understudy” role. Joinder will not
`
`impact the trial schedule because the proceeding based on the Intel Petition is in its
`
`early stages.
`
`The Board has granted joinder in other proceedings when presented with this
`
`fact pattern and procedural history. For example, in Celltrion, Inc. v. Genentech,
`
`Inc., IPR2018-01019, Paper 11 (P.T.A.B. Oct. 30, 2018), the petitioner, Celltrion,
`
`filed a petition with a motion for joinder to Pfizer’s pending petition IPR2017-
`
`01923. Id. at 13. Celltrion had agreed to take an understudy role to Pfizer and no
`
`deadlines in the original IPR were changed. Id. at 14. The Board therefore granted
`
`-2-
`
`

`

`joinder, finding that doing so did not increase the burden on either the patent owner
`
`or the Board, and the timing of petition supported joinder. Id. The Board reached the
`
`same conclusion in Pfizer, Inc. v. Genentech, Inc., IPR2017-02063, Paper 25
`
`(P.T.A.B. Feb. 21, 2018), where Pfizer took “understudy” role to earlier filed and
`
`not-yet-instituted Celltrion petition.
`
`Here, Qualcomm agrees to let Intel take a lead role with Qualcomm taking the
`
`understudy role. Under these circumstances, like those in IPR2017-01063, there is
`
`no undue prejudice to Patent Owner, and therefore the Board should institute IPR
`
`and grant Qualcomm’s Motion for Joinder. See IPR2017-01063, Paper 25 at 3-5.
`
`Accordingly, and for the reasons discussed below, joinder should be granted.
`
`II. BACKGROUND AND RELATED PROCEEDINGS
`Patent Office records indicate that the ’096 patent is assigned to UNM
`
`Rainforest Innovations (“Patent Owner”). Patent Owner, which was formerly named
`
`STC.UNM, has asserted certain claims of the ’096 patent in the following pending
`
`district-court lawsuits: UNM Rainforest Innovations v. ASUSTek Computer, Inc.,
`
`No. 6:20-cv-00142 (W.D. Tex.); UNM Rainforest Innovations v. Dell Techs. Inc. et
`
`al., No. 6:20-cv-00468 (W.D. Tex.); UNM Rainforest Innovations v. D-Link Corp.,
`
`No. 6:20-cv-00143 (W.D. Tex.); UNM Rainforest Innovations v. TP-Link Techs.
`
`Co., No. 6:19-cv-00262 (W.D. Tex.); and UNM Rainforest Innovations v. ZyXEL
`
`Commc’ns Corp., No. 6:20-cv-00522 (W.D. Tex.).
`
`-3-
`
`

`

`On September 14, 2020, Intel filed a petition for inter partes review of this
`
`patent. See Intel Corp. v. UBM Rainforest Innovations, IPR2020-01576, Paper 2
`
`(Sept. 14, 2020). Qualcomm files this motion concurrently with a petition for inter
`
`partes review of the ’096 patent. Qualcomm has not filed any other petitions for
`
`inter partes review of the ’096 patent.
`
`III. ARGUMENT
`The Board may join any person who properly files a petition for inter partes
`
`review to a separate IPR proceeding. 35 U.S.C. § 315(c). A motion for joinder should
`
`“(1) set forth the reasons why joinder is appropriate; (2) identify any new grounds
`
`of unpatentability asserted in the petition; (3) explain what impact (if any) joinder
`
`would have on the trial schedule for the existing review; and (4) address specifically
`
`how briefing and discovery may be simplified.” Macronix Int’l Co., Ltd. v. Spansion
`
`LLC, IPR2014-00898, Paper 15 at 4 (P.T.A.B. Aug. 13, 2014) (citing Kyocera Corp.
`
`v. SoftView LLC, IPR2013-00004, Paper 15 at 4 (P.T.A.B. Apr. 24, 2013)).
`
`Qualcomm’s motion is timely, and the Board should grant joinder because
`
`consideration of the foregoing factors weighs in favor of joinder.
`
`A. Qualcomm’s Motion for Joinder Is Timely
`Joinder may be requested “no later than one month after the institution date
`
`of any inter partes review for which joinder is requested.” 37 C.F.R. § 42.122(b).
`
`Intel’s petition was filed on September 14, 2020 and has not yet been instituted as
`
`-4-
`
`

`

`of filing of this motion. Accordingly, Qualcomm’s motion is timely as it is being
`
`filed within the time set by 37 C.F.R. § 42.122(b). Central Security Group –
`
`Nationwide, Inc. v. Ubiquitous Connectivity, LP, IPR2019-01609, Paper 11, at 8-9
`
`(P.T.A.B. Feb. 26, 2020) (stating that § 42.122(b) is “[t]he only timing requirement
`
`for a motion for joinder”); Dell Inc. v. Neodron Ltd., IPR2020-00731, Paper 9 at 5
`
`(P.T.A.B. July 31, 2020) (granting motion for joinder to an IPR proceeding that was
`
`not instituted until after the motion for joinder was filed).
`
`B.
`The Kyocera Factors Weigh in Favor of Joinder
`Each of the four factors that the Board considers in motions for joinder favor
`
`granting of Qualcomm’s motion. As shown below, joinder will not add further
`
`complication to the proceedings or cause prejudice to the parties. Moreover, joinder
`
`will significantly simplify briefing, discovery and trial associated with review of the
`
`’096 patent.
`
`1.
`
`Joinder of Qualcomm is Appropriate Because It Will
`Promote an Efficient Determination of the Validity of the
`’096 Patent Without Prejudice to Any Party
`If Qualcomm is joined as a party, the validity of the grounds raised in the Intel
`
`Petition and Qualcomm’s Petition can be determined in a single proceeding.
`
`Qualcomm’s Petition challenges the validity of the same claims of the ’096 patent
`
`on identical grounds to those in the Intel Petition. There are no substantive
`
`differences between Intel’s and Qualcomm’s Petitions. See Intel, IPR2020-01576,
`
`-5-
`
`

`

`Paper 2 (Sept. 14, 2020). Qualcomm also relies on substantially the same supporting
`evidence in its Petition as is relied on in the Intel Petition.1 A consolidated
`
`proceeding, including both Intel and Qualcomm, will therefore be more efficient and
`
`less wasteful, as only a single trial on these common grounds would be required.
`
`See, e.g., Oracle America, IPR2016-01672, Paper 13 at 7 (PTAB Mar. 7, 2017)
`
`(noting that “joining Oracle’s identical challenges to those in the 1002 IPR will lead
`
`
`1 Qualcomm submits a copycat declaration from Dr. Sumit Roy, on whom
`
`Qualcomm will rely only in the event that Intel is terminated from the proceedings.
`
`The supporting declaration submitted by Qualcomm only differs from that filed by
`
`Intel (from Dr. Robert Akl) in that it has been updated to list the qualifications and
`
`personal experience of Dr. Roy. The opinions set forth in Dr. Roy’s declaration are
`
`identical to the opinions set forth in the declaration of Dr. Akl filed in the Intel IPR,
`
`and Dr. Roy’s discussion of the prior art and his analysis is the same as the analysis
`
`of Intel’s expert. See Celltrion, Inc. v. Genentech, Inc., IPR2018-01019, Paper 11 at
`
`14 (P.T.A.B. Oct. 30, 2018) (granting motion for joinder of petitioner who “relie[d]
`
`on different experts” when the petitioner “assert[ed] that its ‘copycat declarations’
`
`provide a discussion and analysis that ‘is substantially the same as the analysis of
`
`Pfizer’s experts’ and will not be relied upon unless [the original petitioner] is
`
`terminated from the proceedings.”)
`
`-6-
`
`

`

`to greater efficiency while reducing the resources necessary from both Realtime and
`
`the Board”). In addition, since the parties will be presenting, and the Board will be
`
`determining, the same issues in both IPRs, joinder is the most efficient and
`
`economical manner to proceed. See, e.g., Kingston Tech., 2020 WL 1480468, at *8
`
`(granting joinder of “me too” petition); Mylan Pharmaceuticals Inc. v. Almirall, No.
`
`IPR2019-01095, 2019 WL 6443934, at *4 (P.T.A.B. Nov. 27, 2019) (same); Ariosa
`
`Diagnostics, 2013 WL 6514079, at *1 (granting motion for joinder where the second
`
`petition involved the same parties, the same patent, and much of the same prior art).
`
`Joining Qualcomm as a party to the Intel IPR also would not cause any
`
`prejudice to either Patent Owner or Intel. Patent Owner must respond to the common
`
`invalidity grounds identified in Intel’s and Qualcomm’s Petitions regardless of
`
`joinder. Thus, Patent Owner bears no additional burden. For both Patent Owner and
`
`Intel, Qualcomm’s Petition has been filed sufficiently early so that joinder would
`
`affect neither the potential schedule of the inter partes review, nor the costs
`
`associated with a full trial. See Oracle America, IPR2016-01672, Paper 13 at 7.
`
`Accordingly, this factor favors joinder.
`
`2. Qualcomm’s Petition Does Not Raise Any New Grounds of
`Unpatentability and Therefore Does Not Add Additional
`Complexity to the Grounds in Intel’s Petition
`Qualcomm’s Petition challenges the validity of the ’096 patent on identical
`
`grounds to those in the Intel Petition. See Intel, IPR2020-01576, Paper 29 (Sep. 14,
`
`-7-
`
`

`

`2020). Qualcomm’s supporting materials,
`
`including
`
`its supporting expert
`
`declaration, are also substantially the same as those presented by Intel. See, supra,
`
`n.1. Therefore, consolidation of this proceeding with Intel’s via joinder of
`
`Qualcomm’s Petition will not raise any new issues of unpatentability and will not
`
`impose any additional burden on the Board or add additional complexity to the case.
`
`The Board has granted joinder in similar situations. See, e.g., Hyundai Motor Co. v.
`
`Am Vehicular Scis. LLC, IPR2014-01543, Paper 11 at 2-4 (PTAB Oct. 24, 2014);
`
`Sony Corp. of Am. v. Network-1 Sec Solutions, Inc., IPR2013-00495, Paper 13 at 5-
`
`9 (PTAB Sept. 16, 2013); Dell Inc. v. Network-1 Solutions, Inc., IPR2013- 00385,
`
`Paper 17 at 6-10 (PTAB July 29, 2013); Motorola Mobility, IPR2013- 00256, Paper
`
`10 at 4-10 (PTAB June 20, 2013).
`
`Accordingly, this factor favors joinder.
`
`3.
`Joinder Would Not Affect the Schedule in the Intel IPR
`Given that the Board has not yet instituted review of the Intel petition, joinder
`
`of Qualcomm would not affect the schedule in any forthcoming trial. In addition,
`
`joining Petitioner’s proceeding will not add any procedural complications or delay
`
`the progress of resolving the substantive issues pending in the Intel IPR because it
`
`will not introduce any new prior art, expert opinions that substantially differ from
`
`those previously filed, or grounds of unpatentability into the Intel IPR. Qualcomm’s
`
`-8-
`
`

`

`participation would result in no changes to the schedule or otherwise unfairly
`
`prejudice the Patent Owner.
`
`Accordingly, this factor favors joinder.
`
`4.
`
`Joinder Will Simplify Briefing and Discovery Because
`Qualcomm Has Agreed to Consolidated Filings and an
`Understudy Role
`To further prevent joinder from imposing any burden on Intel or Patent Owner
`
`and to further ensure that there are no changes in the potential trial schedule,
`
`Qualcomm agrees, as long as Intel remains a party to the review, to (1) coordinate
`
`any communications with Intel’s expert through Intel’s counsel; (2) not produce its
`
`own testifying witnesses; and (3) not file substantive papers (except for those
`
`associated with Board-approved motions that do not affect Intel or Intel’s position).
`
`Qualcomm also will confer and cooperate with Intel on the consolidated
`
`filings but, as long as Intel is a party to the review, Intel will make all final decisions
`
`and will retain responsibility for oral argument (including telephone hearings and
`
`appeals). Qualcomm will not seek or receive separate time and will not separately
`
`argue during oral argument, including telephone hearings and appeals, except when
`
`addressing Board-approved motions that do not affect Intel or Intel’s position.
`
`Qualcomm also will coordinate the discovery and testimony relating to
`
`witnesses with Intel but, as long as Intel is a party to the review, Intel will make all
`
`final decisions. In particular, as long as Intel is a party to the review, Qualcomm will
`
`-9-
`
`

`

`not separately file or serve objections or discovery requests, will not receive separate
`
`cross examination or redirect time, will not separately cross examine or redirect any
`
`witness, and agrees that cross examinations will occur within the timeframe
`
`normally allotted to one party without a need for extension in light of the joinder.
`
`Thus, for briefing and document submissions, as long as Intel remains a party
`
`to the inter partes review, the Board may order petitioners to consolidate filings such
`
`that Intel would submit papers on behalf of petitioners and Qualcomm would not be
`
`allowed additional filings. Moreover, for depositions, no adjustments to the schedule
`
`would be required and, indeed, no additional depositions would be necessary.
`
`Qualcomm will not rely on expert testimony beyond that submitted by Intel unless
`
`Intel is terminated from the case prior to any necessary depositions. Thus, Dr. Roy
`
`would not be relied on if Intel’s expert remains available. Absent termination of Intel
`
`from the proceedings, Qualcomm will participate only in a secondary “understudy”
`
`role. However, if Intel is no longer a party, Qualcomm will be free to rely on the
`
`opinions and testimony of Dr. Roy, and other declarants for Intel that are already of
`
`record.
`
`As a result of the foregoing, by consolidating filings with Intel, Patent Owner
`
`will only need to respond to one principal set of papers. No further time to address
`
`additional arguments will be required by any party, and the consolidated trial can
`
`thus proceed at the same pace as if Qualcomm was not joined. Torrent Pharm Ltd,
`
`-10-
`
`

`

`v. UCB Pharma GMBH, IPR2016-01636, Paper 10 at 5 (PTAB Dec. 7, 2016);
`
`Amerigen Pharm Ltd, v. UCB Pharma GMBH, IPR2016-01665, Paper 8 at 6 (PTAB
`
`Dec. 7, 2016).
`
`Accordingly, this factor favors joinder.
`
`C. The Board Has Granted Joinder under these Circumstances,
`Finding No Undue Burden or Prejudice
`As discussed above, the Board has granted joinder in other petitions, with facts
`
`that mirror those here. Qualcomm has agreed to take an understudy role and no
`
`deadlines in the Intel IPR will not be affected. Therefore, the Board should institute
`
`IPR and grant Qualcomm’s Motion for Joinder.
`
`IV. CONCLUSION
`For the foregoing reasons, Qualcomm respectfully requests that the Board
`
`grant its concurrently filed Petition for inter partes review of the ’096 patent and
`
`join the grounds of invalidity therein raised with Intel IPR2020-01576.
`
`Respectfully submitted,
`
` /
`
` Jonathan I. Detrixhe /
`Lead Counsel
`Jonathan I. Detrixhe (Reg. No. 68,556)
`Reed Smith LLP
`101 Second Street
`Suite 1800
`San Francisco, CA 94105
`Tel: 415.543.8700
`Fax: 415.391.8269
`
`-11-
`
`
`
`Dated: December 28, 2020
`
`

`

`jdetrixhe@reedsmith.com
`
`Back-up Counsel
`Jonah D. Mitchell (will seek pro hac vice
`admission)
`Christine M. Morgan (will seek pro hac vice
`admission)
`Reed Smith LLP
`101 Second Street
`Suite 1800
`San Francisco, CA 94105
`Tel: 415.543.8700
`Fax: 415.391.8269
`jmitchell@reedsmith.com
`cmorgan@reedsmith.com
`
`Peter J. Chassman (Reg. No. 38,841)
`Reed Smith LLP
`811 Main Street
`Suite 1700
`Houston, TX 77002
`Tel: 713.469.3800
`Fax: 713.469.3899
`pchassman@reedsmith.com
`
`Ismail C. Kuru (will seek pro hac vice admission)
`Reed Smith LLP
`10 S. Wacker Dr. 40th Floor
`Chicago, IL, 60606
`Tel: 312.207.1000
`Fax: 312.207.6400
`ikuru@reedsmith.com
`
`
`Counsel for Petitioner
`
`-12-
`
`
`
`

`

`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that true copies of the foregoing Motion for
`
`Joinder has been served this 23rd day of December, 2020, by FedEx® mail delivery
`
`service on Patent Owner at the correspondence address for the attorney of record for
`
`the ’096 Patent shown in USPTO PAIR:
`
`FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP
`901 NEW YORK AVENUE, NW
`WASHINGTON DC 20001-4413
`and via electronic mail to the attorneys of record for Plaintiff in the related litigation
`
`matter:
`
`Charles L. Ainsworth - Charley@pbatyler.com
`Robert Christopher Bunt - Rcbunt@pbatyler.com
`Michael W. Shore - mshore@shorechan.com
`Alfonso G. Chan - achan@shorechan.com
`William D. Ellerman - wellerman@shorechan.com
`Corey M. Lipschutz - clipschutz@shorechan.com
`Dated December 28, 2020
`Respectfully submitted,
`/ Jonathan I. Detrixhe /
`Jonathan I. Detrixhe (Reg. No. 68,556)
`Reed Smith LLP
`101 Second Street
`Suite 1800
`San Francisco, CA 94105
`Tel: 415.543.8700
`Fax: 415.391.8269
`jdetrixhe@reedsmith.com
`Counsel for Petitioner
`
`13
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket